Sweet Syndrome: A Comprehensive Review of Pathogenesis, Clinical Manifestations, Diagnosis, and Management Strategies
Main Article Content
Abstract
Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is a rare and inflammatory disorder characterized by fever, neutrophilia, and tender, erythematous skin lesions. The pathogenesis of Sweet syndrome involves an exaggerated immune response, with evidence suggesting a role for cytokines, particularly granulocyte colony-stimulating factor (G-CSF). Clinical manifestations vary widely, but commonly include abrupt onset of painful, raised plaques or nodules, often on the upper limbs, face, or neck. Histopathological examination reveals dense neutrophilic infiltrates in the dermis without evidence of vasculitis.
Diagnosis is primarily clinical, supported by histopathology and exclusion of other similar conditions. Treatment typically involves corticosteroids, which often lead to rapid resolution of symptoms. However, relapses are common, necessitating long-term management strategies. This review aims to provide a comprehensive overview of the pathogenesis, clinical manifestations, diagnosis, and management of Sweet syndrome, highlighting recent advancements and areas requiring further research.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. SWEET RD. AN ACUTE FEBRILE NEUTROPHILIC DERMATOSIS. Br J Dermatol. 1964 Aug-Sep;76:349-56.
II. Bhat AG, Siddappa Malleshappa SK, Pasupula DK, Duke W, Shaaban R. Bullous Variant of Sweet's Syndrome as a Consequence of Radioiodine Contrast Exposure. Cureus. 2018 Oct 24;10(10):e3490.
III. Vettakkara KMN, Banerjee S, Mittal A, Goel P, Kumar P, Baitha U, Jorwal P, Soneja M, Biswas A. Not so sweet; severe Sweet's syndrome presenting as SIRS and pleural effusion. J Family Med Prim Care. 2018 Nov-Dec;7(6):1584-1587
IV. Stevens G J, Yutronic H J, Pizarro O J, Velozo P L. Sweet Syndrome in Pediatrics. A case report. Rev Chil Pediatr. 2018 Aug;89(4):511-515.
V. Nelis S, Azerad MA, Drowart A, Lewalle P, Efira A. [Sweet's syndrome induced by pegfilgrastim during a myelodysplastic syndrome AREB2: A case report]. Rev Med Interne. 2019 Apr;40(4):258-261.
VI. Arun Kumar AU, Elsayed ME, Alghali A, Ali AA, Mohamed H, Hussein W, Hackett C, Leonard N, Stack AG. Sweet syndrome: a rare feature of ANCA-associated vasculitis or unusual consequence of azathioprine-induced treatment. Allergy Asthma Clin Immunol. 2018;14:46.
VII. Adil A, Goyal A, Quint JM. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Feb 22, 2023. Behcet Disease.
VIII. Corbeddu M, Pilloni L, Pau M, Pinna AL, Rongioletti F, Atzori L. Treatment of Sweet's syndrome in pregnancy. Dermatol Ther. 2018 Jul;31(4):e12619.
IX. Takahama H, Kanbe T. Neutrophilic dermatosis of the dorsal hands: a case showing HLA B54, the marker of Sweet's syndrome. Int J Dermatol. 2010 Sep;49(9):1079-80.
X. Jo T, Horio K, Migita K. Sweet's syndrome in patients with MDS and MEFV mutations. N Engl J Med. 2015 Feb 12;372(7):686-8.
XI. Colović MD, Janković GM, Novak AZ, Strahinja RM, Colović NR. Sweet's syndrome associated with paracentric inversion of chromosome 3q in a patient with multiple myeloma. Eur J Haematol. 1996 Aug;57(2):188-9.
XII. Mijovic A, Novak A, Medenica L. Sweet's syndrome associated with inversion of chromosome 3q in a patient with refractory anemia. Eur J Haematol. 1992 Sep;49(3):156-7.
XIII. Gurnari C, Franceschini L, Anemona L, Passarelli F, Vaccarini S, Pupo L, Provenzano I, Nasso D, Rizzo M, Cantonetti M. Recurrent Sweet's syndrome in a patient with multiple myeloma. Clin Case Rep. 2018 Oct;6(10):1958-1960.